|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.010 USD | -3.63% |
|
+2.39% | -60.44% |
| 07-08 | Quoin Pharmaceuticals & CFO Gordon Dunn agree to a mutual separation | RE |
| 07-08 | Quoin Pharmaceuticals Ltd. Announces Mutual Separation with CFO Gordon Dunn | CI |
Evolution of the Average Target: Quoin Pharmaceuticals, Ltd.
Evolution of the Target Price: Quoin Pharmaceuticals, Ltd.
Changes in Analyst Recommendations: Quoin Pharmaceuticals, Ltd.
efd8e59ae352014c0.cKs3uQTmtM8mfhjgbJnAyV7Nry-Xtnx_V7LywVwoMnA.IZ5a7DSWx5dNGHSUK6i4gQS-xEuj0A0lIeKarC5GAxogwH7oRY_z-2kmcw~a72c07b3697054a5549e6b309fd904f4
More recommendations
| Consensus (Composite) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +1,564.78% | ||||||
| +15.58% | ||||||
| +30.61% | ||||||
| +20.93% | ||||||
| +15.19% | ||||||
| -1.47% | ||||||
| +15.74% | ||||||
| +33.1% | ||||||
| +3.85% | ||||||
| +11.91% | ||||||
| Average | +171.02% | |||||
| Weighted average by Cap. | +17.71% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
9.010USD
Average target price
150.00USD
Spread / Average Target
+1,564.78%
High Price Target
350.00USD
Spread / Highest target
+3,784.49%
Low Price Target
30.00USD
Spread / Lowest Target
+232.96%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Maxim | |
| Ladenburg Thalmann | |
| JMP Securities | |
| Alliance Global Partners |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- QNRX Stock
- Consensus Quoin Pharmaceuticals, Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition